These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7511473)

  • 21. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
    Radulovic S; Comaru-Schally AM; Milovanovic S; Schally AV
    Pancreas; 1993 Jan; 8(1):88-97. PubMed ID: 8093555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vapreotide: BMY 41606, RC 160, Sanvar.
    Drugs R D; 2003; 4(5):326-30. PubMed ID: 12952505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Treatment Options for Neuroendocrine Tumors.
    Kulke MH
    J Natl Compr Canc Netw; 2017 May; 15(5S):737-739. PubMed ID: 28515259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study.
    Canobbio L; Boccardo F; Cannata D; Gallotti P; Epis R
    Cancer; 1992 Feb; 69(3):648-50. PubMed ID: 1346097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palliative interventions in patients with peritoneal metastases and malignant bowel obstruction.
    Bellavance EC; Alexander HR
    J Clin Oncol; 2012 Dec; 30(35):4290-1. PubMed ID: 23109693
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of vapreotide, a somatostatin analogue, on gastric acidity, gallbladder emptying and hormone release after 1 week of continuous subcutaneous infusion in normal subjects.
    Ritz MA; Drewe J; Ziel A; Hildebrand P; Schneider P; Lahlou N; Beglinger C
    Br J Clin Pharmacol; 1999 Feb; 47(2):195-201. PubMed ID: 10190655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules.
    Zalatnai A; Schally AV
    Cancer Res; 1989 Apr; 49(7):1810-5. PubMed ID: 2564312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin analogs in the management of gastrointestinal tumors.
    Lamberts SW
    Horm Res; 1988; 29(2-3):118-20. PubMed ID: 2900191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nausea is a common symptom in palliative care. Choice of treatment is based on the cause].
    Strang P; Jakobsson M
    Lakartidningen; 1999 Apr; 96(14):1743-5. PubMed ID: 10222693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of patients with advanced prostatic cancer to administration of somatostatin analog RC-160 (vapreotide) at the time of relapse.
    González-Barcena D; Schally AV; Vadillo-Buenfil M; Cortez-Morales A; Hernández L V; Cardenas-Cornejo I; Comaru-Schally AM
    Prostate; 2003 Aug; 56(3):183-91. PubMed ID: 12772187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The palliative effects of octreotide in malignant disease.
    Dean A; Bridge D; Lickiss JN
    Ann Acad Med Singap; 1994 Mar; 23(2):212-5. PubMed ID: 7521613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elderly patients with pancreatic cancer.
    Kougioumtzopoulou AS; Syrigos KN; Saif MW
    JOP; 2014 Jul; 15(4):322-5. PubMed ID: 25076333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
    Caplin ME; Pavel M; Ćwikła JB; Phan AT; Raderer M; Sedláčková E; Cadiot G; Wolin EM; Capdevila J; Wall L; Rindi G; Langley A; Martinez S; Blumberg J; Ruszniewski P;
    N Engl J Med; 2014 Jul; 371(3):224-33. PubMed ID: 25014687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
    Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
    Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bulbar duodenal adenocarcinoma. An unsuspected diagnosis].
    Téllez-Villajos L; Garrido-Gómez E; Martín-De-Argila C; Gil-Grande L; Tavío-Hernández E; Albillos-Martínez A
    Gastroenterol Hepatol; 2014 Apr; 37(4):251-3. PubMed ID: 24314791
    [No Abstract]   [Full Text] [Related]  

  • 36. Paralytic ileus responding to somatostatin therapy: first manifestation of a VIPoma.
    Koberstein B; Layer P; Balzer K; Müller MK; Singer MV; Goebell H
    Dig Dis Sci; 1989 Nov; 34(11):1803-4. PubMed ID: 2573486
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucagonoma syndrome: diagnosis and treatment.
    Zeng J; Wang B; Ma D; Li F
    J Am Acad Dermatol; 2003 Feb; 48(2):297-8. PubMed ID: 12582409
    [No Abstract]   [Full Text] [Related]  

  • 38. Somatostatin analogue SMS 201-995 long term therapy for vipoma.
    Juby LD; Burke DA; Axon AT
    Postgrad Med J; 1987 Apr; 63(738):287-9. PubMed ID: 2891127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Phan AT; Kunz PL; Reidy-Lagunes DL
    Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours.
    Modlin IM; Pavel M; Kidd M; Gustafsson BI
    Aliment Pharmacol Ther; 2010 Jan; 31(2):169-88. PubMed ID: 19845567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.